Started with a modest capital of Rs. 3 crores in 1992, the Ozone Group achieve d a turnover of Rs. 125 crores in 2008 – 09. Today the group is one of the India's emerging „Specialty healthcare groups that discovers, develops, manufactures and markets health care products. The Group has two main divisions, pharmaceuticals, and consumer health care. The Consumer healthcare business of the Group consists of over-the–counter (OTC) medicines, skin care products, such as the brands NOMARKS, ITIS & KWIK. The pharmaceuticals division is the largest part of The Ozone Group businesses and can be divided into prescription drugs and vaccines.
Headquartered in New Delhi, the group also has an international operation which is handled from its office in UK. The group operates in 21 international markets, the major ones being West Europe, North America, the Middle East, Africa and the South East U.K. The Ozone Group is a knowledge-driven enterprise and its continuous investment in R&D has enabled the group to develop innovative processes, products and technologies. The manufacture and supply system of the Group operates as a single global network. The company has two manufacturing sites and employs around 1,700 employees in Himachal Pradesh (Baddi) and Assam (Guwahati). The manufacturing process employs state of the art technology in production, quality control and packaging, in a pollution-free environment that meets international standards.
For details on Ozone Group please visit –